Behçet's syndrome is not associated with vitiligo

Area of Science:

• Rheumatology
• Dermatology
• Immunology

Background:

• Behçet's syndrome (BS) presents distinct features compared to autoimmune diseases.
• Vitiligo commonly co-occurs with autoimmune disorders like thyroiditis and Addison's disease.
• An informal observation suggested vitiligo is rare in BS patients.

Purpose of the Study:

• To formally investigate the prevalence of vitiligo in Behçet's syndrome patients.
• To compare vitiligo frequency in BS patients with those of Graves' disease, Hashimoto's thyroiditis, and healthy controls.

Main Methods:

• A controlled, masked study surveyed 253 BS patients, 34 Graves' disease patients, 32 Hashimoto's thyroiditis patients, and 439 healthy controls.
• Dermatological examination with Wood's lamp confirmed suspected hypopigmented lesions.
• Patients were recruited from university hospital rheumatology and endocrinology departments.

Main Results:

• No BS patients exhibited vitiligo.
• Vitiligo was diagnosed in 17.6% of Graves' disease patients and 18.7% of Hashimoto's thyroiditis patients.
• Vitiligo occurred in 0.9% of healthy controls, with most affected individuals being women.

Conclusions:

• Vitiligo frequency is not elevated in Behçet's syndrome patients.
• This finding contrasts with the higher prevalence of vitiligo in Graves' disease and Hashimoto's thyroiditis.
• The results imply that conventional autoimmune mechanisms may not drive Behçet's syndrome pathogenesis.